Use the Search Fields to Find Information
Page 134 of 375
Medical Cannabis for Gynecologic Pain Conditions
Please use this link to access publication OBJECTIVE: The endocannabinoid system is involved in pain perception and inflammation. Cannabis contains delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD),
February 28, 2024
Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
Abstract Objectives. Assessing the effectiveness and tolerability of medical cannabis (MC) treatment on Gilles de la Tourette syndrome (GTS) patients. Methods. We report on an
March 16, 2022
Medical cannabis for chronic pain management: questions and answers between clinical and medico-legal issues
Abstract Medical cannabis (MC) has gained prominence in recent years as a potential therapeutic option for various diseases, with a particular focus on chronic pain
April 26, 2026
Medical Cannabis for Chronic Nonmalignant Pain Management
Abstract Purpose of Review Cannabis has been used since ancient times for medical and recreational research. This review article will document the validity of how
September 5, 2024
Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations
Abstract Purpose. Medical cannabis for patients with chronic noncancer pain (CNCP) has been the focus of numerous health care recommendations. We conducted a systematic review
June 16, 2025
Medical cannabis education among healthcare trainees: A scoping review
Abstract Objectives It has been previously demonstrated that healthcare professionals would like additional education on medical cannabis. However, there has not yet been a review of
August 23, 2025
Medical Cannabis Dosing Trajectories of Patients: Evidence From Sales Data
Please use this link to access this publication. Highlights •Our study reveals diverse Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) dosing patterns among patients with medical conditions,
February 27, 2025
Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases
Abstract Cannabis preparations are gaining popularity among patients with various skin diseases. Due to the lack of scientific evidence, dermatologists remain cautious about their prescriptions.
March 28, 2024
Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
Abstract Background Cannabis is increasingly used for therapeutic purpose. However, its safety profile is not well known. This study assessed the risk of cardiovascular-related emergency
July 4, 2025
Medical Cannabis and Utilization of Nonhospice Palliative Care Services: Complements and Alternatives at End of Life
Abstract Background and Objectives There is a need to know more about cannabis use among terminally diagnosed older adults, specifically whether it operates as a
March 25, 2024
Page 134 of 375